ImmunoCellular Therapeutics, Ltd. (NASDAQOTCBB:IMUC.OB)

CAPS Rating 1 out of 5 
IMUC.OB VS S&P 500 (SPY)

How do you think IMUC.OB will perform against the market?

Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPS

All Players

17 Outperform
14 Underperform
 

All-Star Players

5 Outperform
10 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top IMUC.OB Bull/Bear Pitches

zzlangerhans (99.67)
Submitted October 22, 2011

Hard to believe I'm green-thumbing a company who pays for promotion by VFC. That's kind of like paying Gaddafi to manage your public relations. And sometimes I can't remember the difference between ImmunoCellular and Northwest. But I'm seeing… More

Fools bullish on IMUC.OB
are also bullish on:

zzlangerhans (99.67)
Submitted May 25, 2012

Not very long ago, a company called Northwest Biotherapeutics was the glioblastoma tumor vaccine stock to own. Just like ImmunoCellular, articles hyping the stock were published on a regular basis on Seeking Alpha. Just like ImmunoCellular, they… More

Fools bearish on IMUC.OB
are also bearish on:

Featured Broker Partners


Advertisement